Elbasvir/Grazoprevir in Women With Hepatitis C Virus Infection Taking Oral Contraceptives or Hormone Replacement Therapy

International Journal of Women's Health- New Zealand

doi 10.2147/ijwh.s203022

Full Text

Abstract

Available in

Date

Authors

Publisher

Informa UK Limited

Related search

Effectiveness of Elbasvir/Grazoprevir in US Veterans With Chronic Hepatitis C Virus Genotype 1b Infection

Infectious Diseases and Therapy
Infectious DiseasesMicrobiology
2020English

An Integrated Analysis of Elbasvir/Grazoprevir in Korean Patients With Hepatitis C Virus Genotype 1b Infection

Clinical and molecular hepatology
MedicineHepatologyMolecular Biology
2019English

Elbasvir/Grazoprevir for Patients With Hepatitis C Virus Infection and Inherited Blood Disorders: A Phase III Study

Hepatology
MedicineHepatology
2017English

Short-Duration Treatment With Elbasvir/Grazoprevir and Sofosbuvir for Hepatitis C: A Randomized Trial

Hepatology
MedicineHepatology
2016English

Blood Pressure in Women Taking Oral Contraceptives

American Heart Journal
Cardiovascular MedicineCardiology
1976English

Blood Pressure in Women Taking Oral Contraceptives

BMJ
1974English

The Relation of Growth Hormone to Altered Carbohydrate Metabolism in Women Taking Oral Contraceptives

Journal of Clinical Pathology
MedicineForensic MedicinePathology
1972English

Antiviral Activity and Resistance Analysis of NS3/4A Protease Inhibitor Grazoprevir and NS5A Inhibitor Elbasvir in Hepatitis C Virus GT4 Replicons

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2017English

Spotlight on Grazoprevir—elbasvir Once-Daily Combination and Its Potential in the Treatment of Hepatitis C

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy